Invention Grant
US09120870B2 Dual specific binding proteins directed against IL-13 and IL-17
有权
针对IL-13和IL-17的双重特异性结合蛋白
- Patent Title: Dual specific binding proteins directed against IL-13 and IL-17
- Patent Title (中): 针对IL-13和IL-17的双重特异性结合蛋白
-
Application No.: US13729645Application Date: 2012-12-28
-
Publication No.: US09120870B2Publication Date: 2015-09-01
- Inventor: Chung-Ming Hsieh , Tariq Ghayur , Carrie L. Goodreau
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/46 ; A61K45/06 ; G01N33/68 ; C07K16/24
Abstract:
Engineered multivalent and multispecific binding proteins that bind IL-13 and/or IL-17 are provided, along with methods of making and uses in the prevention, diagnosis, and/or treatment of disease.
Public/Granted literature
- US20130236458A1 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-13 AND/OR IL-17 Public/Granted day:2013-09-12
Information query
